Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
Academic Press Inc (Verlag)
978-0-12-802810-0 (ISBN)
The book explores diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of Alzheimer’s Disease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why these drugs tend to fail at the clinical stage, and examines Alzheimer’s Disease within the overall context of improving the drug discovery process for the treatment of other neurodegenerative disorders.
Adeboye Adejare’s research group is interested in the areas of design and syntheses of small organic molecules to probe neurodegeneration, especially Alzheimer’s disease, and for treatment of cancer. They are also interested in in vitro models of drug absorption and ability to cross blood brain barrier; drug targeting; pharmaceutical profiling; and chemistry of fluoroaromatic compounds. The research is funded by the National Institutes of Health, the Office of Naval Research, and several pharmaceutical companies. These efforts have resulted in over 50 publications, 5 patents, and over 100 presentations at meetings, including invited presentations at national and international conferences. He also serves on several national panels, including those by NIH, NSF, and Alzheimer’s Association. Dr. Adejare is the editor of Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease which is also published by Elsevier.
1. General description of neurodegenerative disorders 2. Alzheimer’s disease diagnosis 3. National plan and resources to address Alzheimer’s disease 4. Current Medications for Treatment of Alzheimer's Disease: Acetylcholine esterase inhibitors and NMDA receptor antagonist 5. Physicochemical properties for potential AD drugs 6. Receptor approaches 7. Amyloid hypothesis 8. Tau proteins 9. Cholesterol and fat metabolism 10. Energy Metabolism 11. Simple in vivo models of Neurodegeneration (C. Elegans, fruitfly, and similar models) 12. Rodent Models 13. Clinical Trials 14. Non-pharmacologic Treatment Approaches
| Erscheinungsdatum | 14.10.2016 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 750 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Geriatrie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| ISBN-10 | 0-12-802810-6 / 0128028106 |
| ISBN-13 | 978-0-12-802810-0 / 9780128028100 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
